Providers/Grant Support
Jointly provided by Partners for Advancing Clinical Education (Partners) and DKBmed, LLC.
This activity is supported by an educational grant from Lilly.
Credits Available
- Physicians — maximum of 0.75 AMA PRA Category 1 Credits™
- Physician Assistants — 0.75 AAPA Category 1 CME credits
- Nurses — 0.75 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
The intended audience for this Infograph-ed activity will be neurology specialists (neurologists, neuropsychiatrists) and primary care clinicians (MD, PA, NP, RN) seeing patients with Alzheimer’s disease.
Program Overview
Approximately 7.2 million Americans are currently living with Alzheimer’s disease, and that number is projected to nearly double by 2060. But innovations in diagnosis and treatment have the potential to change that projection if applied properly.
This interactive, gamified learning experience follows a 73-year-old patient through real-world office visits. You’ll explore how to:
- Differentiate normal aging from early cognitive impairment
- Address disparities in Alzheimer’s diagnosis and access to care
- Apply validated cognitive screening tools appropriately
- Identify appropriate candidates for biologic therapy
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Analyze how emerging diagnostic tools can be used to facilitate a faster diagnosis of AD.
- Appraise the benefits of various blood-based biomarker assessments for diagnosis of AD.
- Assess the role of available disease-modifying treatments for patients with AD.
Faculty
Paul B. Rosenberg, MD
Professor of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Baltimore, MD
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and DKBmed LLC. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Education
Partners designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.
PA Continuing Medical Education
Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until March 29, 2027. PAs should only claim credit commensurate with the extent of their participation.
Disclosures of Conflict of Interest
Paul B. Rosenberg, MD
- Consultant, Advisor, Speaker: Acadia, Leerink, Lilly, Medalink, Noble Insights, Novo Nordisk, Otsuka
- Researcher: Eisai
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
To access activities, users will need:
- A computer with an internet connection
- An HTML5 compliant web browser or Internet Explorer 8 (and higher)
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participating and receiving CME/CE credit for this activity.
Contact Information
For additional information about the accreditation of this activity, please visit https://partnersed.com.